Non-Hodgkins Lymphoma Pathology Flashcards

(61 cards)

1
Q
A

Normal lymph node

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the “dark zone” of the lymph node?

A

area that is reacting to Ag → centroblasts are undergoing proliferation, somatic mutation & isotype switching

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Centrocytes

A

small cleaved lymphocytes exhibiting surface Ab in the light zone

(centroblasts are in the dark zone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mantle zone of lymph node contains _____

A

naive b-cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Marginal zone (just outside mantle zone) contains ______ (2)

A
  1. naive B-cell
  2. memory B-cells

(they’re just chillin’)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ki67 role in dx

A

proliferation marker for lymph follicle

(proliferation may be normal, but it can aid in dx)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Non-Hodgkin’s Lymphoma (malignant lymphoma) arises within the _____.

A

lymph nodes, not in bone marrow (can metastasize there though)

(or other organs rich in lymphoid tissue; leukemias arise in bone marrow and metastasize to lymph nodes. “leukemia/lymphoma” used when we aren’t sure where it started first)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Neoplastic cells are monoclonal, how can we tell if the cells (T cell or B cells) are monoclonal?

A
  1. B cells: light chain restriction
  2. T cells: TCR arrangement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CD5+ is a good dx marker for which 2 N-H lymphomas?

A
  1. SLL/CLL
  2. Mantle

(Rules out follicular and marginal zone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hodgkin’s Lymphoma (malignant lymphoma) risk factors (3)

A
  1. Immunodeficiency
  2. Chronic autoimmune diz
  3. Chronic infections

(immune system being overly stimulated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

2 Clinical findings of Non-Hodgkin’s Lymphoma (malignant lymphoma)

A
  1. painless lymphadenopathy
  2. B-type sx: fatigue, fever, wt. loss, night sweats

(may have extranodal sx if metastasized: abdominal pain, rash, sensorimotor, chest pain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Low-grade lymphoma is well differentiated tumor; High-grade is a poorly differentiated tumor. Which has the better prognosis?

A

Low-grade

(low grade: painless lymphadenopathy, no B-symptoms; high-grade is the opposite)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hodgkin’s lymphoma staging is the similar as leukemia. What is the general staging?

A

1: 1 lymph node involved or single extranodal site

1B: + systemic sx (B-sx)

2: 2+ lymph nodes on same side of diaphragm
3: both sides of diaphragm
4: extranodal involvement, both sides of diaphragm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do you tell the difference between benign and malignant lymph node changes?

A
  • malignant: painful
  • benign: gets better, goes down

(bx to confirm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the main finding that indicates a benign reactive changes (hyperplastic) of lymph nodes?

A

interfollicular area (spaces btwn follicles)

(mantle zone, dark/light zones present)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the most important immunophenotypic finding of benign changes to the lymph node?

A

bcl-2 negative (anti-apoptotic protein) in the follicle

(CD3+, CD20+ cells present)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why is this a neoplastic follicle (2)?

A
  1. loss of zonal definition w/absent mantle zone (loss of polarity)
  2. No tingible body MF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MC form of adult indolent NHL?

A

follicular lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Mutation in follicular lymphoma (type of NHL)

A

t(14;18) → BCL-IgH fusion gene

(anti-apoptotic effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Key terms of histopathology that indicate follicular lymphoma?

A
  1. atypical lymphocyte
  2. cleaved v. non-cleaved

(more importantly, look for cytogenetics and immunophenotype)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MC type of NHL?

A

diffuse large B-cell lymphoma (also MC adult NHL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Diffuse Large B-Cell lymphoma may arise from which two hematologic cancers?

A
  1. Follicular lymphoma
  2. CLL→Richter transformation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

dx?

(left: intermediate power; right: high power)

A

Diffuse B-cell Lymphoma (high grade tumor)

(any lymph node may be affected)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What does this tell you?

A

CD10 is a malignant marker

(found in Burkitt lymphoma, follicular & diffuse large b-cell. Next you need to determine cytogenetics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
CD10+, CD19+, CD20+ w/Surface Ig + (light chain restriction) and a BCL6 rearrangement of **3q27** indicates which hematologic cancer?
diffuse large B cell lymphoma | (bcl-2 t(11;14) is 2nd MC)
26
Diffuse B cell Lymphoma is most common in which demographic?
~ 60 y/o men
27
Diffuse B-cell Lymphoma typically appears w/ a rapidly growing \_\_\_\_\_\_.
mass (nodal or extra nodal)
28
Waldeyer ring, liver/spleen or skin are common locations of _____ in diffuse b-cell lymphoma
rapidly growing mass that appears
29
Untreated, diffuse B-cell lymphoma prognosis
* ~55% survive 5 years w/treatment (rituximab) * rapidly fatal w/o treatment (\<1 year) → intensive chemo
30
What is a dangerous side effect of chemotherapy when treating aggressive cancer?
tumor lysis syndrome: electrolyte dump from the dying cells (hypercalcemia, hyperkalemia)
31
Why is this follicular lymphoma (2)?
1. follicular enlargement of different sizes and shapes 2. decreased interfollicular spacing
32
Follicular lymphoma is a \_\_\_\_\_\_-grade tumor
low
33
The majority of follicular lymphoma have extranodal involvement, such as \_\_\_\_\_\_(4)
1. ***_bone marrow_*** 2. spleen 3. liver, GI 4. CNS (note DLBCL does NOT involve bone marrow until late course)
34
Bone marrow bx in follicular lymphoma will show \_\_\_\_\_\_
paratrabecular lymphoid aggregates
35
Any time there is a B-cell malignancy you may see _____ (3).
1. Autoimmune hemolytic anemia 2. thrombocytopenia 3. M-spike (paraproteins from clonal cells → hemolytic anemia or M-spike)
36
Both follicular lymphoma, DLBCL, and Mantle Cell lymphoma present at _____ stage
III/IV
37
\_\_\_\_\_\_\_ presents as **waxing and waning** with painless lymphadenopathy in older adults.
Follicular lymphoma
38
How can you tell a follicular lymphoma apart from benign changes in the lymph node?
benign changes will be CD5(-) (and CD43(-); both may be nodular)
39
\_\_\_\_\_\_\_ are the only 3 lymphomas that are CD5+.
1. Mantle cell 2. CLL/SLL 3. Hairy cell (mantle cell is CD23(-); CLL/SLL are CD23+)
40
Both DLBCL, FL & Mantle Cell Lymphoma have SIg+ with light chain restriction. Which has IgM w/or w/o IgD?
FL
41
Mantle cell (NHL) is CD23(-); CLL/SLL are CD23+. What is one other distinguishing factor between them?
Mantle cell has NO proliferation centers (lymphoblastic lymphomas have homogenous proliferation cells)
42
CD5+, CD10- distinguishes Mantle Cell Lymphoma from \_\_\_\_\_\_
follicular (which is CD10+)
43
CD5+, CD10- distinguishes Mantle Cell Lymphoma from \_\_\_\_\_\_
follicular
44
Mutation t(11;14) → cylinD1-IgH fusion indicates \_\_\_\_\_\_
Mantle Cell Lymphoma (this allows bypass of normal G1-S phase regulation)
45
Mantle cell lymphoma has a good short-term prognosis, but poor long-term without \_\_\_\_\_
bone marrow transplant | (usually causes organ failure)
46
What is a “blastoid variant” of mantle cell lymphoma?
proliferative profile (even worse prognosis)
47
Mantle cell lymphoma involves _____ cells, this is the reason why there is no somatic hypermutation.
naive B cells (in contrast to Marginal Zone Lymphoma, which involves mature B cells)
48
\_\_\_\_\_\_\_ presents as a **disseminated** disease in older males. (hint: may also involve GI polyps)
Mantle cell lymphoma
49
**t(11;18)** mutation, MALTomas (80% of cases) & chronic inflammation are diagnostic features of \_\_\_\_\_\_.
marginal zone lymphoma (mature B cells; also lack of other markers you would expect to see)
50
Chronic inflammation of \_\_\_\_\_\_\_3 glands can lead to Marginal zone lymphoma.
1. **stomach (H.pylori or celiac)** 2. salivary (Sjogren's) 3. thyroid (Hashimoto's) (may regress if this inflammation is cured, i.e. abx)
51
(stomach tissue)
MALToma: effacement by malignant lymphocytes (will produce GI sx: nausea, anorexia, pain)
52
(stomach
effacement by malignant lymphocytes
53
CD19/20/10+, BL6, “starry sky” histology and failure to express BCL-2 is diagnostic of \_\_\_\_\_\_
Burkitt lymphoma (the fastest growing human tumor) (also EBV association)
54
“starry sky” describes \_\_\_\_\_
histology of burkitt lymphoma: tingible MF phagocytizing apoptotic debris
55
“tingible body” macrophage
56
Burkitt lymphoma: vacuoles + deep blue cytoplasm
57
t(\_\_\_;\_\_\_) → _____ fusion is present in the majority of Burkitt lymphoma cases
t(8;14) → MYC-IgH | (this leads to the Warburg effect)
58
All cases of African/endemic Burkitt lymphoma are from a _____ and primarily affect the \_\_\_\_\_.
* latent EBV infection * mandible or small intestine (very aggressive, mass can appear w/in weeks; fastest growing human tumor)
59
**Sporadic** Burkitt lymphoma is a common childhood cancer that is NOT associated with ______ and is commonly located in the \_\_\_\_\_.
* EBV * distal ileum and cecum (African/endemic burkitt is assoc. w/EBV)
60
EBV & HTLV-1 are associated with which malignancy?
Peripheral T cell Lymphoma | (mature T cells)
61
CD3+, CD4+ w/diffusely effaced LN & B-symptoms is diagnostic of \_\_\_\_\_\_\_
nodal cell lymphoma (note: it is CD8(-))